Synapse - Thoracic Oncology

Results (47)

A podcast discussion on the intracranial efficacy of antibody–Drug conjugates in patients with EGFR-mutated NSCLC with brain metastases

Editorial

Johnson, M. L.; Lin, J. J.; Boire, A.; Khandekar, M. J.; Yu, H. A.
Oncology and Therapy (2025)

Fulltext@MSK | Save

A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors

Journal Article

Scott, S. C.; Farago, A.; Lai, W. V.; Zahurak, M.; Rudek, M. A.; Murray, J.; Carducci, M. A.; Uziel, T.; Takebe, N.; Gore, S. D.; more...
Cancer Chemotherapy and Pharmacology (2025)

Fulltext@MSK | Save

Are there features that can predict the unresectability of pleural mesothelioma?

Journal Article

Mayoral, M.; Araujo-Filho, J. A. B.; Tan, K. S.; Ortiz, E.; Adusumilli, P. S.; Rusch, V.; Zauderer, M.; Ginsberg, M. S.
European Radiology (2025)

Fulltext@MSK | Save

Adavosertib in combination with olaparib in patients with refractory solid tumors: An open-label, dose-finding, and dose-expansion Phase Ib trial

Journal Article

Hamilton, E. P.; Falchook, G. S.; Wang, J. S.; Fu, S.; Oza, A. M.; Imedio, E. R.; Kumar, S.; Ottesen, L.; Mugundu, G. M.; de Bruin, E. C.; more...
Targeted Oncology (2024)

Fulltext@MSK | Save

Clinical characteristics and outcomes of patients with well-differentiated papillary peritoneal mesothelial tumors

Journal Article

Offin, M.; Aguirre, N.; Yang, S. R.; Sauter, J. L.; Karagkounis, G.; Mohamed, M.; Cercek, A.; Kundra, R.; Zhang, Y.; Wang, H. M.; more...
Annals of Surgical Oncology (2024)

Fulltext@MSK | Save

Modelling the effectiveness of tepotinib in comparison to standard-of-care treatments in patients with advanced non-small cell lung cancer (NSCLC) harbouring METex14 skipping in the UK

Journal Article

Batteson, R.; Hook, E.; Wheat, H.; Hatswell, A. J.; Vioix, H.; McLean, T.; Alexopoulos, S. T.; Baijal, S.; Paik, P. K.
Targeted Oncology (2024)

Fulltext@MSK | Save

Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumors

Journal Article

Calvo, E.; Sessa, C.; Harada, G.; de Miguel, M.; Kahatt, C.; Luepke-Estefan, X. E.; Siguero, M.; Fernandez-Teruel, C.; Cullell-Young, M.; Stathis, A.; more...
Investigational New Drugs (2022)

Fulltext@MSK | Save

Murine fecal microbiota transfer models selectively colonize human microbes and reveal transcriptional programs associated with response to neoadjuvant checkpoint inhibitors

Journal Article

Shaikh, F. Y.; Gills, J. J.; Mohammad, F.; White, J. R.; Stevens, C. M.; Ding, H.; Fu, J.; Tam, A.; Blosser, R. L.; Domingue, J. C.; more...
Cancer Immunology, Immunotherapy (2022)

Fulltext@MSK | Save

Matching-adjusted indirect comparison (MAIC) of tepotinib with other MET inhibitors for the treatment of advanced NSCLC with MET exon 14 skipping mutations

Journal Article

Paik, P. K.; Pfeiffer, B. M.; Vioix, H.; Garcia, A.; Postma, M. J.
Advances in Therapy (2022)

Fulltext@MSK | Save

Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma

Journal Article

Zauderer, M. G.; Alley, E. W.; Bendell, J.; Capelletto, E.; Bauer, T. M.; Callies, S.; Szpurka, A. M.; Kang, S.; Willard, M. D.; Wacheck, V.; more...
Investigational New Drugs (2021)

Fulltext@MSK | Save